SLB, Splunk And 2 Other Stocks Insiders Are Selling
Portfolio Pulse from Lisa Levin
Insiders at Lattice Semiconductor Corporation (LSCC), Splunk Inc. (SPLK), Schlumberger Limited (SLB), and T2 Biosystems, Inc. (TTOO) have recently sold shares. While insider sales can sometimes indicate concern about a company's prospects, they can also be part of a preplanned sale. Rosenblatt reiterated LSCC with a Buy and maintained a $110 price target. Cisco announced it will acquire SPLK for roughly $28 billion. Citigroup maintained SLB with a Buy and raised the price target from $66 to $70. The FDA cleared TTOO's biothreat panel for commercial distribution.
September 26, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Insider at Lattice Semiconductor Corporation sold shares. Rosenblatt reiterated the company with a Buy and maintained a $110 price target.
While the insider sale could indicate concern about the company's prospects, the reiteration of a Buy rating by Rosenblatt suggests positive sentiment towards the company. The impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Insider at Schlumberger Limited sold shares. Citigroup maintained the company with a Buy and raised the price target from $66 to $70.
While the insider sale could indicate concern about the company's prospects, the maintenance of a Buy rating and a raised price target by Citigroup suggests positive sentiment towards the company. The impact on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Insider at Splunk Inc. sold shares. Cisco announced it will acquire the company for roughly $28 billion.
Despite the insider sale, the announcement of the acquisition by Cisco is a significant positive development for the company and is likely to boost the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Insider at T2 Biosystems, Inc. sold shares. The FDA cleared the company's biothreat panel for commercial distribution.
Despite the insider sale, the FDA clearance of the company's biothreat panel for commercial distribution is a significant positive development for the company and is likely to boost the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 85
RELEVANCE 100